Of breast cancers, triple-negative breast cancer (TNBC), which is defined by the absence of hormone receptor expression and HER2 overexpression, has more aggressive biologic features and poor prognosis2, 3, 4. This evidence concerns the gene ERBB2 and breast carcinoma.